Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADUSE: AdMSC for Refractory Ischemic Digital Ulcers in Scleroderma
NCT04356755Phase 2Recruiting
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Sep 2020
- Primary completion
- Mar 2027
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of adipose derived mesenchymal stromal cells in systemic sclerosis (SSc), digital ulcer (DU), sponsored by Centre hospitalier universitaire de Toulouse. Started Sep 2020; status: recruiting.
02
Drugs
adipose derived mesenchymal stromal cells
03
Conditions
systemic sclerosis (SSc)digital ulcer (DU)
Beyond the preview
Go deeper on NCT04356755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04356755.